首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1547507

全球荷爾蒙避孕藥市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Hormonal Contraceptives Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球荷爾蒙避孕藥市場需求預計將從 2023 年的 233.5 億美元達到近 358.5 億美元的市場規模，2024-2032 年研究期間複合年成長率為 4.88%。

荷爾蒙避孕藥是常用的節育方法。它含有少量人造雌激素和黃體酮。荷爾蒙避孕藥的主要目的是破壞正常的荷爾蒙平衡，抑制排卵並防止懷孕。荷爾蒙避孕藥有多種形式，分別是陰道環、荷爾蒙釋放避孕線圈、皮膚貼片和避孕藥。它也用於治療多囊性卵巢症候群（PCOS），安全可靠。荷爾蒙避孕藥分為複方荷爾蒙避孕藥和純黃體素避孕藥。由於更好的功效和可用性，複方荷爾蒙避孕藥的需求量很大。分銷管道包括婦科中心、門診手術中心、醫院、診所和家庭護理。

市場動態

人們對荷爾蒙避孕藥的使用和益處的認知不斷提高，特別是在新興經濟體，以及意外懷孕發生率的增加是全球荷爾蒙避孕藥市場成長的關鍵驅動力。促進其市場成長的其他因素包括不穩定的人際關係、女性選擇優先考慮自己的職業、月經人口數量的增加以及控制人口成長的需要。此外，公司之間的合作夥伴關係研發以開發功效更好的荷爾蒙避孕藥，以及與性健康相關的政府意識計劃可能會推動市場成長。然而，荷爾蒙避孕藥的副作用、無荷爾蒙避孕藥的可用性、對生物製劑的偏好以及缺乏社會接受度正在限制荷爾蒙避孕藥市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球荷爾蒙避孕藥市場的每個細分市場進行了包容性評估。荷爾蒙避孕藥產業的成長和趨勢為本研究提供了整體方法。

市場區隔

荷爾蒙避孕藥市場報告的這一部分提供了國家和區域層面的細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

依方法

丸
子宮內避孕器 (IUD)
可注射
陰道環
注入
修補

透過荷爾蒙

複方荷爾蒙避孕藥
僅孕激素

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲荷爾蒙避孕藥市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。荷爾蒙避孕藥市場的主要參與者包括艾伯維公司、Afaxys公司、梯瓦製藥工業有限公司、拜耳公司、默克公司、歐加農集團公司、輝瑞公司、Agile Therapeutics、楊森製藥公司、羽扇豆製藥公司Inc.、Pregna International Ltd. 本部分包含競爭格局的整體視圖，其中包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布以及其他事態發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：荷爾蒙避孕藥公司的競爭格局

荷爾蒙避孕藥市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Abbvie Inc.

公司概況
公司收入
產品
最新動態

Afaxys Inc.

公司概況
公司收入
產品
最新動態

Teva Pharmaceuticals Industries Ltd.

公司概況
公司收入
產品
最新動態

Bayer AG

公司概況
公司收入
產品
最新動態

Merck & Co. Inc.

公司概況
公司收入
產品
最新動態

Organon Group Of Companies

公司概況
公司收入
產品
最新動態

Pfizer

公司概況
公司收入
產品
最新動態

Agile Therapeutics

公司概況
公司收入
產品
最新動態

Janssen Pharmaceuticals Inc.

公司概況
公司收入
產品
最新動態

Lupin Pharmaceuticals Inc.

公司概況
公司收入
產品
最新動態

Pregna International Ltd

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11215136

The global demand for Hormonal Contraceptives Market is presumed to reach the market size of nearly USD 35.85 Billion by 2032 from USD 23.35 Billion in 2023 with a CAGR of 4.88% under the study period 2024-2032.

Hormonal contraceptives are common methods of birth control. It contains man-made estrogen and progesterone in small amounts. The main purpose of hormonal contraceptives is to disrupt normal hormone balance, suppress ovulation and prevent pregnancy. Hormonal contraceptives come in various forms, namely vaginal ring, hormone-releasing contraceptive coils, skin patches and birth control pill. It is also used to manage polycystic ovary syndrome (PCOS) and is safe and reliable. Hormonal contraceptives are categorized as combination hormonal contraceptives and progestin-only contraceptives. Combined hormonal contraceptives are high in demand due to better efficacy and availability. Distribution channels include gynecology centers, ambulatory surgical centers, hospitals, clinics, and home care.

MARKET DYNAMICS

Increasing awareness related to the use and benefits of hormonal contraceptives, especially in emerging economies, and increasing incidence of unwanted pregnancies are acting as key drivers for global hormonal contraceptive market growth. Other factors that contribute to its market growth are unstable relationships, women opting to prioritize their careers, the increasing number of menstruating population, and the need for controlling population growth. Furthermore, partnerships between companies for R&D to develop hormonal contraceptives with better efficacy and government awareness programs related to sexual health are likely to fuel market growth. However, the side effects of hormonal contraceptives, availability of hormone-free contraceptives, preference for biologics, and lack of social acceptability are restraining hormonal contraceptive market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Hormonal Contraceptives. The growth and trends of Hormonal Contraceptives industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Hormonal Contraceptives market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Method

Pill
Intrauterine Device (IUD)
Injectable
Vaginal Ring
Implant
Patch

By Hormone

Combination Hormonal Contraceptives
Progestin Only

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Hormonal Contraceptives market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Hormonal Contraceptives market include Abbvie Inc., Afaxys Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Merck & Co. Inc., Organon Group Of Companies, Pfizer, Agile Therapeutics, Janssen Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Pregna International Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. HORMONAL CONTRACEPTIVES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Method
- 3.7.2 Market Attractiveness Analysis By Hormone
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL HORMONAL CONTRACEPTIVES MARKET ANALYSIS BY METHOD

5.1. Overview By Method
5.2. Historical and Forecast Data
5.3. Analysis By Method
5.4. Pill Historic and Forecast Sales By Regions
5.5. Intrauterine Device (IUD) Historic and Forecast Sales By Regions
5.6. Injectable Historic and Forecast Sales By Regions
5.7. Vaginal Ring Historic and Forecast Sales By Regions
5.8. Implant Historic and Forecast Sales By Regions
5.9. Patch Historic and Forecast Sales By Regions

6. GLOBAL HORMONAL CONTRACEPTIVES MARKET ANALYSIS BY HORMONE

6.1. Overview By Hormone
6.2. Historical and Forecast Data
6.3. Analysis By Hormone
6.4. Combination Hormonal Contraceptives Historic and Forecast Sales By Regions
6.5. Progestin Only Historic and Forecast Sales By Regions

7. GLOBAL HORMONAL CONTRACEPTIVES MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE HORMONAL CONTRACEPTIVES COMPANIES

8.1. Hormonal Contraceptives Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF HORMONAL CONTRACEPTIVES INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Abbvie Inc.
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Afaxys Inc.
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Teva Pharmaceuticals Industries Ltd.
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Bayer AG
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Merck & Co. Inc.
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Organon Group Of Companies
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Pfizer
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Agile Therapeutics
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Janssen Pharmaceuticals Inc.
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Lupin Pharmaceuticals Inc.
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments
9.13. Pregna International Ltd
- 9.13.1 Company Overview
- 9.13.2 Company Revenue
- 9.13.3 Products
- 9.13.4 Recent Developments